{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:04:07Z","timestamp":1789070647920,"version":"build-2803163510"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"NINGBO Medical & Health Leading Academic Discipline Project","award":["2022-Z04"],"award-info":[{"award-number":["2022-Z04"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Primary cutaneous lymphomas (PCLs), comprising cutaneous T-cell lymphomas (CTCLs) and cutaneous B-cell lymphomas (CBCLs), are rare non-Hodgkin lymphomas with distinct epidemiological characteristics. How the incidence rates (IRs) of PCLs have changed over the past decade has not been well documented.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To assess changes in IRs in overall and subtype-specific PCLs in the USA by sex, age and ethnic group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study analysed 13 126 cases of PCL diagnosed between 2010 and 2021 using data from the Surveillance, Epidemiology and End Results programme. Age-adjusted IRs (aaIRs), 5-year relative survival and annual percentage change were calculated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The overall aaIR of PCLs was 11.9 per 1 000 000 person-years, with 8.8 for CTCLs and 3.1 for CBCLs. Among CTCL subtypes, mycosis fungoides had the highest aaIR of 5.2, whereas within CBCLs, primary cutaneous marginal zone lymphoma exhibited the highest aaIR of 1.4. Between 2014 and 2021, the aaIR of CBCLs declined annually by 4.9%. In males, aaIRs for CTCLs and CBCLs decreased by 3.5% and 4.8%, respectively, per year over the same period. Five-year relative survival was 89.3% for CTCLs and 91.5% for CBCLs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The incidence of PCLs has exhibited distinct patterns of decline among different population groups over the past decade. The continued disparities in both incidence and survival underscore the need for targeted research and interventions to mitigate demographic inequalities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ced\/llaf535","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T13:21:21Z","timestamp":1764768081000},"page":"620-625","source":"Crossref","is-referenced-by-count":3,"title":["Emerging epidemiological trends in primary cutaneous lymphomas: a population-based analysis"],"prefix":"10.1093","volume":"51","author":[{"given":"Yanwu","family":"Lu","sequence":"first","affiliation":[{"name":"Dermatology Medical Cosmetology Center, Ningbo Municipal Hospital of Traditional Chinese Medicine (TCM), Affiliated Hospital of Zhejiang Chinese Medical University , Zhejiang ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Dermatology Medical Cosmetology Center, Ningbo Municipal Hospital of Traditional Chinese Medicine (TCM), Affiliated Hospital of Zhejiang Chinese Medical University , Zhejiang ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqi","family":"Ying","sequence":"additional","affiliation":[{"name":"Dermatology Medical Cosmetology Center, Ningbo Municipal Hospital of Traditional Chinese Medicine (TCM), Affiliated Hospital of Zhejiang Chinese Medical University , Zhejiang ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"issue":"Suppl. 1","key":"2026032611540706100_llaf535-B1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/hon.2584","article-title":"Cutaneous lymphomas \u2013 an update 2019","volume":"37","author":"Kempf","year":"2019","journal-title":"Hematol Oncol"},{"key":"2026032611540706100_llaf535-B2","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO\u2013EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood"},{"key":"2026032611540706100_llaf535-B3","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO\u2013EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"2026032611540706100_llaf535-B4","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1182\/blood-2008-10-184168","article-title":"Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases","volume":"113","author":"Bradford","year":"2009","journal-title":"Blood"},{"key":"2026032611540706100_llaf535-B5","doi-asserted-by":"crossref","first-page":"104109","DOI":"10.1016\/j.lpm.2022.104109","article-title":"Cutaneous B-cell lymphomas: update on diagnosis, risk-stratification, and management","volume":"51","author":"Fava","year":"2022","journal-title":"Presse Med"},{"key":"2026032611540706100_llaf535-B6","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.hoc.2024.05.012","article-title":"Cutaneous T-cell lymphoma","volume":"38","author":"Weiner","year":"2024","journal-title":"Hematol Oncol Clin North Am"},{"key":"2026032611540706100_llaf535-B7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.clml.2012.06.010","article-title":"Age, race, sex, stage, and incidence of cutaneous lymphoma","volume":"12","author":"Wilson","year":"2012","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"2026032611540706100_llaf535-B8","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1001\/jamaoncol.2022.3236","article-title":"Incidence trends of primary cutaneous T-cell lymphoma in the US from 2000 to 2018: a SEER population data analysis","volume":"8","author":"Cai","year":"2022","journal-title":"JAMA Oncol"},{"key":"2026032611540706100_llaf535-B9","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/bjd.19644","article-title":"Epidemiological changes in cutaneous lymphomas: an analysis of 8593 patients from the French Cutaneous Lymphoma Registry","volume":"184","author":"Dobos","year":"2021","journal-title":"Br J Dermatol"},{"key":"2026032611540706100_llaf535-B10","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/bjd.12516","article-title":"Incidence of primary cutaneous T-cell lymphoma in Wales","volume":"169","author":"Abbott","year":"2013","journal-title":"Br J Dermatol"},{"key":"2026032611540706100_llaf535-B11","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1365-2133.2008.08852.x","article-title":"Incidence of primary cutaneous T-cell lymphoma in Norway","volume":"160","author":"Saunes","year":"2009","journal-title":"Br J Dermatol"},{"key":"2026032611540706100_llaf535-B12","first-page":"643","article-title":"Care structure of patients with mycosis fungoides and S\u00e9zary syndrome in Germany \u2013 care research based on SHI claims data","volume":"20","author":"Assaf","year":"2022","journal-title":"J Dtsch Dermatol Ges"},{"key":"2026032611540706100_llaf535-B13","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3109\/10428194.2014.956315","article-title":"The heterogeneity of changes in incidence and survival among lymphoid malignancies in a 30-year French population-based registry","volume":"56","author":"Dandoit","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"2026032611540706100_llaf535-B14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5045\/br.2022.2022037","article-title":"Basic immunohistochemistry for lymphoma diagnosis","volume":"57","author":"Cho","year":"2022","journal-title":"Blood Res"},{"key":"2026032611540706100_llaf535-B15","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41392-023-01451-2","article-title":"Immunosenescence: molecular mechanisms and diseases","volume":"8","author":"Liu Z, Liang Q, Ren Y","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"2026032611540706100_llaf535-B16","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12979-018-0130-y","article-title":"Immunosenescence and lymphomagenesis","volume":"15","author":"Mancuso","year":"2018","journal-title":"Immun Ageing"},{"key":"2026032611540706100_llaf535-B17","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1001\/archderm.143.7.854","article-title":"Incidence of cutaneous T-cell lymphoma in the United States, 1973\u20132002","volume":"143","author":"Criscione","year":"2007","journal-title":"Arch Dermatol"},{"key":"2026032611540706100_llaf535-B18","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jamadermatol.2013.5526","article-title":"Changing incidence trends of cutaneous T-cell lymphoma","volume":"149","author":"Korgavkar","year":"2013","journal-title":"JAMA Dermatol"},{"key":"2026032611540706100_llaf535-B19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000018423","article-title":"Mycosis fungoides: review of epidemiological observations","volume":"201","author":"Morales Su\u00e1rez-Varela","year":"2000","journal-title":"Dermatology"},{"key":"2026032611540706100_llaf535-B20","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.3390\/cancers12102921","article-title":"Epidemiology of cutaneous T-cell lymphomas: a systematic review and meta-analysis of 16,953 patients","volume":"12","author":"Dobos","year":"2020","journal-title":"Cancers (Basel)"},{"key":"2026032611540706100_llaf535-B21","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.3390\/ijerph110404449","article-title":"Non-Hodgkin lymphoma and occupational exposure to agricultural pesticide chemical groups and active ingredients: a systematic review and meta-analysis","volume":"11","author":"Schinasi","year":"2014","journal-title":"Int J Environ Res Public Health"},{"key":"2026032611540706100_llaf535-B22","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1002\/cncr.30758","article-title":"Comprehensive analysis of cutaneous T-cell lymphoma (CTCL) incidence and mortality in Canada reveals changing trends and geographic clustering for this malignancy","volume":"123","author":"Ghazawi","year":"2017","journal-title":"Cancer"},{"key":"2026032611540706100_llaf535-B23","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jaad.2021.01.041","article-title":"Mapping cutaneous T-cell lymphoma in the state of Florida: a retrospective exploratory spatial analysis of incidence patterns","volume":"86","author":"Malachowski","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"2026032611540706100_llaf535-B24","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1158\/2159-8290.CD-21-1207","article-title":"Genomic and single-cell landscape reveals novel drivers and therapeutic vulnerabilities of transformed cutaneous T-cell lymphoma","volume":"12","author":"Song","year":"2022","journal-title":"Cancer Discov"},{"key":"2026032611540706100_llaf535-B25","doi-asserted-by":"crossref","unstructured":"Nath SK, Yu JB, Wilson LD. \u00a0Poorer prognosis of African-American patients with mycosis fungoides: an analysis of the SEER dataset, 1988 to 2008. Clin Lymphoma Myeloma Leuk \u00a02014; 14:419\u201323.","DOI":"10.1016\/j.clml.2013.12.018"},{"key":"2026032611540706100_llaf535-B26","doi-asserted-by":"crossref","first-page":"e174","DOI":"10.1016\/j.clml.2023.12.017","article-title":"Racial disparities in mycosis fungoides\/S\u00e9zary syndrome \u2013 a single-center observational study of 292 patients","volume":"24","author":"Gandham","year":"2024","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"2026032611540706100_llaf535-B27","first-page":"633","article-title":"Racial disparities in the clinical presentation and prognosis of patients with mycosis fungoides","volume":"111","author":"Huang","year":"2019","journal-title":"J Natl Med Assoc"},{"key":"2026032611540706100_llaf535-B28","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/bjd\/ljae039","article-title":"Significant survival disparity in Black patients with cutaneous lymphoma: a retrospective cohort study","volume":"190","author":"Trum","year":"2024","journal-title":"Br J Dermatol"},{"key":"2026032611540706100_llaf535-B29","doi-asserted-by":"crossref","first-page":"adv40505","DOI":"10.2340\/actadv.v104.40505","article-title":"Cutaneous T-cell lymphoma diagnostic and therapeutic trends amidst the COVID-19 pandemic","volume":"104","author":"Roccuzzo","year":"2024","journal-title":"Acta Derm Venereol"},{"key":"2026032611540706100_llaf535-B30","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/cyto.b.21878","article-title":"Flow cytometric evaluation of peripheral blood for suspected S\u00e9zary syndrome or mycosis fungoides: international guidelines for assay characteristics","volume":"100","author":"Horna","year":"2021","journal-title":"Cytometry B Clin Cytom"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llaf535\/65736655\/llaf535.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/51\/4\/620\/65736655\/llaf535.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/51\/4\/620\/65736655\/llaf535.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T15:54:16Z","timestamp":1774540456000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/51\/4\/620\/8364810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,12,4]]},"published-print":{"date-parts":[[2026,3,26]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llaf535","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2025,12,4]]}}}